Magmatic Bio
PrivateLast Round
Grant
Nov 26, 2024
Total Funding Raised
$900,000
Company Overview
Magmatic Bio is a biotechnology company that develops custom synthetic proteins designed for metal separation and regeneration to advance circularity in critical minerals.
Sector
Frontier & Industrial Tech
Verticals
Biotechnology, Advanced Materials, Circular Economy, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Magmatic Bio Comparables
Compare Magmatic Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Giraffe Bio | 84% | |
| MicroMiner | 83% | |
| CaptuREE | 82% |
Magmatic Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 26, 2024 | ||||
| Accelerator | Oct 16, 2024 |
Magmatic Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nucleus Capital | Accelerator, Seed |
| Founders Factory | Accelerator |
| FFG Austrian Research Promotion Agency | Grant |
Magmatic Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Magmatic Bio's valuation, stock price, and market status.
Is Magmatic Bio a public or private company?
Magmatic Bio is a private company.
What is the current stock price of Magmatic Bio?
Magmatic Bio is a private company, so its shares have no public market price. Caplight tracks Magmatic Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Magmatic Bio worth (valuation)?
Valuation information for Magmatic Bio is not publicly available.
Can I buy Magmatic Bio stock?
Magmatic Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Magmatic Bio's last funding round?
Magmatic Bio's most recent funding round was Grant on November 26, 2024.
Who are the main investors in Magmatic Bio?
Key investors in Magmatic Bio include Nucleus Capital, Founders Factory, FFG Austrian Research Promotion Agency.
Will Magmatic Bio IPO soon?
No public IPO plans have been announced for Magmatic Bio.
How can I track Magmatic Bio secondary market activity?
Caplight tracks bids, offers, and trades in Magmatic Bio's shares on secondary markets.